References
1. Thurston RC, Huang AJ. The Swinging Pendulum of Menopausal Hormone Therapy. JAMA Intern Med. 2025;185(12):1411-1412. https://doi.org/10.1001/jamainternmed.2025.5340
2. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://doi.org/10.1001/jama.288.3.321
3. Manson JE, Aragaki AK, Rossouw JE, et al.; WHI Investigators. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. JAMA. 2017;318(10):927-938. https://doi.org/10.1001/jama.2017.11217
4. "The 2022 Hormone Therapy Position Statement of The North American Menopause Society" Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://doi.org/10.1097/GME.0000000000002028
5. Asociación Española para el Estudio de la Menopausia (AEEM), Sociedad Española de Ginecología y Obstetricia (SEGO). Posicionamiento AEEM-SEGO sobre terapia hormonal de la menopausia. Prog Obstet Ginecol. 2019 Jan. doi:10.20960/j.pog.00094. https://doi.org/10.20960/j.pog.00094
6. Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis. 2016;254:282-290. https://doi.org/10.1016/j.atherosclerosis.2016.10.005

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 María Jesús Cancelo-Hidalgo, Mónica Retuerta Pría

